Dataset SeBluCo study: SARS-CoV-2-antibodies among German blood donors 2020 – 2022, a repetitive cross-sectional study

The dataset is the result of a repetitive cross-sectional study in 28 regions in Germany on SARS-CoV-2 antibodies in residual samples of blood donors from April 2020 to April 2021, September 2021 and April/May 2022. These data were used to aide in monitoring the pandemic in Germany. Data were completely anonymised at the site of sample collection. Serological test results are accompanied by demographic data including sex, age and area of residence (assigned a level two Nomenclature des Unités Territoriales Statistiques (NUTS2)). 
The file contains data (sheet "data") as well as the description of variable content and coding (sheet "variables").